Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
A pilot study of high sensitivity troponin-T testing to facilitate safe early disposition decisions in patients presenting to the Emergency Department with chest pain *

Background: Many patients present to emergency departments with chest pain but little is known about this population and the safest, most efficient testing strategies.

Aims: We assessed clinical risk stratification of all patients with chest pain and, on a subset, utility of high sensitivity troponin at 4 and 6 hours after pain onset in aiding disposition decisions.

Methods: Patients with intermediate or high risk chest pain presenting within 6 hours of onset were eligible for detailed study of troponin testing and outcome. Confusion, inability to speak English, or need for urgent angiography were exclusions. Troponin levels were performed on arrival and at 4, 6 and 10-24 hours from chest pain onset. Thirty day follow-up assessed compliance with, and results of, further investigation.

Results: Chest pain accounted for 627 presentations over 112 days. Of 282 intermediate or high risk presentations 144 (51%) presented more than 6 hours after onset. The detailed study enrolled 52 patients with a troponin rise observed in 26%. In no cases did troponin increase between 6 and 10 hours and, in five cases, fell. Follow-up was achieved in 96%. Eight high risk patients (40%) and 4 intermediate risk patients (13%) had positive stress tests. For discharged patients with outpatient investigations booked in ED 92% attended whilst those with letters recommending investigations did not obtain testing.

Conclusions: This preliminary data suggests that high sensitivity troponin six hours after chest pain onset may be diagnostically useful. Marked differences in outpatient testing attendance suggest bookings should be made before discharge.


* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 08-18-2009
Authors: Dr Richard Paoloni 1 , Dr Priya Kumar 2 and Margaret Janu 3
Source: 2007 The Authors Journal compilation